Alwin Krämer

12PUBLICATIONS
64CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursDevelopmental genetics (incl. sex determination)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 03, 2026
Molecularly Guided Therapy Versus Continued Chemotherapy in Unfavorable Cancer of Unknown Primary: Updated Efficacy and Safety From the Randomized, Phase II CUPISCO Study.

|Aug 18, 2025
Arsenic Trioxide and All-Trans Retinoic Acid Combination Therapy for the Treatment of High-Risk Acute Promyelocytic Leukemia: Results From the APOLLO Trial.

Uwe Platzbecker, Lionel Adès, Pau Montesinos

|Aug 04, 2025
Rethinking cancer of unknown primary: from diagnostic challenge to targeted treatment.

Maria Pouyiourou, Tilmann Bochtler, Chantal Pauli

|Oct 28, 2024
STIL overexpression shortens lifespan and reduces tumor formation in mice.

Amira-Talaat Moussa, Marco R Cosenza, Timothy Wohlfromm

|Jan 04, 2024
Frequency and Prognostic Value of Circulating Tumor Cells in Cancer of Unknown Primary.

Maria Pouyiourou, Tilmann Bochtler, Cornelia Coith

|Oct 24, 2023
Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trial.

Maria Pouyiourou, Bianca N Kraft, Timothy Wohlfromm

Pageof 2

Frequent Collaborators

4 joint publications

Albrecht Stenzinger

4 joint publications

Tilmann Bochtler

3 joint publications

Maria Pouyiourou

2 joint publications

Thomas Hielscher